Journal Feed Weekly Wrap-Up

We always work hard, but we may not have time to read through a bunch of journals. It’s time to learn smarter.
Originally published at JournalFeed, a site that provides daily or weekly literature updates.
Follow Dr. Clay Smith at @spoonfedEM, and sign up for email updates here.

#1: High-Dose Nitroglycerin for SCAPE – But How High?

Spoon Feed
High-dose nitroglycerin improves outcomes in patients with sympathetic crashing acute pulmonary edema (SCAPE) without significant side effects when compared to low-dose nitroglycerin.

Source
High-dose versus low-dose intravenous nitroglycerine for sympathetic crashing acute pulmonary edema: a randomised controlled trial. Emerg Med J. 2023 Nov 28:emermed-2023-213285. doi: 10.1136/emermed-2023-213285. Online ahead of print

#2: Septic Kids (And Their Kidneys) Like Balanced Fluids

Spoon Feed
The use of balanced crystalloid (PlasmaLyte A) rather than normal saline (0.9% sodium chloride) reduced acute kidney injury and improved other outcomes in these pediatric patients with septic shock.

Source
Multiple Electrolytes Solution Versus Saline as Bolus Fluid for Resuscitation in Pediatric Septic Shock: A Multicenter Randomized Clinical Trial. Crit Care Med. 2023 Nov 1;51(11):1449-1460. doi: 10.1097/CCM.0000000000005952. Epub 2023 Jun 9.

#3: TENSION RCT – Thrombectomy for Large-Infarct Volume Strokes

Spoon Feed
Endovascular thrombectomy plus medical care is better than medical care for patients with large vessel occlusion (LVO), even with established large infarcts.

Source
Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial. Lancet. 2023 Nov 11;402(10414):1753-1763. doi: 10.1016/S0140-6736(23)02032-9. Epub 2023 Oct 11. PMID: 37837989.

Leave a Reply

Your email address will not be published. Required fields are marked *

EMDOCS IN YOUR MAILBOX

Enter your email address to receive notifications of new posts by email.

Featured Articles

emDocs is licensed under a Creative Commons Attribution 4.0 International License. Powered by Gomalthemes.